Does classical immunity acquired by the subcontinent population become advantageous to manage COVID-19 due to the low rate of mortality?

The global pandemic due to the COVID-19 has severely affected the entire world risking human life and economy. Every possible attempt becomes inadequate in controlling the disease as the number rising each passing day. Indeed, a highly populated country like India has so far successful in mitigating the outbreak within the country. Meanwhile, the strategy based on a preliminary model of assumption with massive awareness program on social (physical) distancing, compulsory wearing of a mask and nationwide lockdown might have contributed immensely to controlling such an emergency. However, the influence of the immune-competent genetic architecture of the Indian racing population and comparatively a dominant young age group population cannot be ruled out completely. Moreover, a suitable environment for viral propagation and characteristics of viral strain are other such factors that simultaneously could add a real scientific justification. However, the current global scenario indicating the countries with higher median age are severely affected compared to the Indian and African subcontinent thereby survived an outbreak with a low mortality rate. At the same time, we never claimed for complete immunity for the COVID-19 depending on age or immunity. The increased incidence of positive cases might slowly also increase the death rate within India, but so far recorded low compared to other parts of the globe.